SPTSSA

serine palmitoyltransferase small subunit A

Basic information

Region (hg38): 14:34432788-34462240

Previous symbols: [ "C14orf147" ]

Links

ENSG00000165389NCBI:171546OMIM:613540HGNC:20361Uniprot:Q969W0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spastic paraplegia 90A, autosomal dominant (Strong), mode of inheritance: AD
  • spastic paraplegia 90B, autosomal recessive (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spastic paraplegia 90A, autosomal dominant; Spastic paraplegia 90B, autosomal recessive AD/ARAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Neurologic36718090

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPTSSA gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPTSSA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
3
clinvar
3
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 3 0 0

Variants in SPTSSA

This is a list of pathogenic ClinVar variants found in the SPTSSA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-34435209-C-T not specified Uncertain significance (Mar 15, 2024)3322534
14-34435244-TGG-T Spastic paraplegia 90B, autosomal recessive Pathogenic (Dec 07, 2023)2505468
14-34435265-G-A SPTSSA-related disorder • Spastic paraplegia 90A, autosomal dominant Conflicting classifications of pathogenicity (Dec 07, 2023)2505470
14-34462156-A-C not specified Uncertain significance (Oct 20, 2021)2255922
14-34462156-A-T not specified Uncertain significance (Jan 04, 2022)2269218
14-34462198-T-C not specified Uncertain significance (Aug 02, 2021)2223447

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPTSSAprotein_codingprotein_codingENST00000298130 229568
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6460.330102420011024210.00000488
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2283640.10.8990.00000201451
Missense in Polyphen49.35880.42741122
Synonymous-0.9702317.81.290.00000101135
Loss of Function1.6903.350.001.44e-736

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001080.0000108
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Stimulates the activity of serine palmitoyltransferase (SPT). The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2- SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16- CoA as substrates, with a slight preference for C14-CoA. {ECO:0000269|PubMed:19416851}.;
Pathway
Metabolism of lipids;Metabolism;ceramide <i>de novo</i> biosynthesis;Sphingolipid de novo biosynthesis;Sphingolipid metabolism (Consensus)

Recessive Scores

pRec
0.113

Intolerance Scores

loftool
rvis_EVS
-0.05
rvis_percentile_EVS
49.39

Haploinsufficiency Scores

pHI
0.184
hipred
N
hipred_score
0.400
ghis
0.608

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
K
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowLow
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sptssa
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;

Gene ontology

Biological process
sphingolipid biosynthetic process;ceramide biosynthetic process
Cellular component
endoplasmic reticulum membrane;integral component of membrane;serine C-palmitoyltransferase complex
Molecular function
serine C-palmitoyltransferase activity;protein binding